Can repeat biopsy be skipped after initial complete resection of T1 bladder cancer? The role of a novel urinary mRNA biomarker
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference28 articles.
1. Bladder cancer incidence and mortality: a global overview and recent trends;Antoni;Eur Urol,2017
2. The optimal management of T1 high-grade bladder cancer;Nepple;Can Urol Assoc J,2009
3. Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016;Ebrahimi;J Urol,2019
4. Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy;Kassouf;Can Urol Assoc J,2010
5. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Urinary mRNA-based biomarkers for non-muscle-invasive bladder cancer: a mini-review;Frontiers in Oncology;2024-08-09
2. Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial);Scientific Reports;2023-09-18
3. A Restaging Transurethral Resection of the Bladder Is Always Necessary for High-grade T1 Non–muscle-invasive Bladder Cancer: Con;European Urology Focus;2023-07
4. Repeat Transurethral Resection for Non–muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era;European Urology Focus;2023-07
5. Urine‐based liquid biopsy in bladder cancer: Opportunities and challenges;Clinical and Translational Discovery;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3